Suppr超能文献

组织工程羊膜治疗心肌梗死:实验研究的系统评价

Tissue-engineered amniotic membrane in the treatment of myocardial infarction: a systematic review of experimental studies.

作者信息

Blume Gustavo Gavazzoni, Machado-Júnior Paulo André Bispo, Paludo Bertinato Giovana, Simeoni Rossana Baggio, Francisco Julio César, Guarita-Souza Luiz César

机构信息

Division of Cardiovascular Diseases, School of Medicine, Catholic University Curitiba, Paraná, Brazil.

出版信息

Am J Cardiovasc Dis. 2021 Feb 15;11(1):1-11. eCollection 2021.

Abstract

OBJECTIVE

myocardial infarction (MI) remains the leading cause of death worldwide. Cell-based therapies have become potential therapeutic approaches, attempting to recover the contractility of necrotic cardiomyocytes. In the present study, we aimed to systematically evaluate experimental studies on the use of tissue-engineered amniotic membrane (hAMC) in MI treatment.

METHODS

a systematic review of literature published in PubMed, Embase and CENTRAL databases was conducted, until March 31, 2020, for experimental studies reporting on hAMC cell-therapy performed on LV function, MI size, paracrine effects, angiogenesis, and cell differentiation. Two reviewers selected the articles that met the inclusion criteria and disagreements were solved through a consensus.

RESULTS

a total of 11 studies were included for data extraction. For the acute scenario, therapeutic use of hAMC after MI was capable of improving LV function in rats, mainly due to its paracrine effects (anti-apoptotic and anti-inflammatory) and associated with cardiomyocyte differentiation, MI size reduction and neo-angiogenesis.

CONCLUSION

tissue engineered hAMC following MI provided clinically relevant benefits on cardiac function and ventricular remodeling.

摘要

目的

心肌梗死(MI)仍是全球主要的死亡原因。基于细胞的疗法已成为潜在的治疗方法,试图恢复坏死心肌细胞的收缩力。在本研究中,我们旨在系统评价关于使用组织工程羊膜(hAMC)治疗MI的实验研究。

方法

对PubMed、Embase和CENTRAL数据库中截至2020年3月31日发表的文献进行系统综述,纳入关于hAMC细胞治疗对左心室功能、MI面积、旁分泌作用、血管生成和细胞分化影响的实验研究。两名评审员筛选符合纳入标准的文章,分歧通过协商解决。

结果

共纳入11项研究进行数据提取。在急性情况下,MI后使用hAMC进行治疗能够改善大鼠的左心室功能,主要归因于其旁分泌作用(抗凋亡和抗炎),并与心肌细胞分化、MI面积缩小和新生血管形成有关。

结论

MI后组织工程化hAMC对心脏功能和心室重构具有临床相关益处。

相似文献

3
Bone-Marrow Stem Cells and Acellular Human Amniotic Membrane in a Rat Model of Heart Failure.
Life (Basel). 2021 Sep 13;11(9):958. doi: 10.3390/life11090958.
5
Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis.
Am J Physiol Heart Circ Physiol. 2017 Aug 1;313(2):H224-H236. doi: 10.1152/ajpheart.00108.2017. Epub 2017 May 26.
6
Mesenchymal stem cell therapy: A promising cell-based therapy for treatment of myocardial infarction.
J Gene Med. 2017 Dec;19(12). doi: 10.1002/jgm.2995. Epub 2017 Dec 8.
7
Mechanistic effects of mesenchymal and hematopoietic stem cells: New therapeutic targets in myocardial infarction.
J Cell Biochem. 2018 Jul;119(7):5274-5286. doi: 10.1002/jcb.26637. Epub 2018 Mar 12.
8
Conditioned medium from human amniotic mesenchymal stromal cells limits infarct size and enhances angiogenesis.
Stem Cells Transl Med. 2015 May;4(5):448-58. doi: 10.5966/sctm.2014-0253. Epub 2015 Mar 30.
10
Reactivating endogenous mechanisms of cardiac regeneration via paracrine boosting using the human amniotic fluid stem cell secretome.
Int J Cardiol. 2019 Jul 15;287:87-95. doi: 10.1016/j.ijcard.2019.04.011. Epub 2019 Apr 4.

引用本文的文献

1
3D morphometry of endothelial cells angiogenesis in an extracellular matrix composite hydrogel.
Heliyon. 2024 Oct 21;10(21):e39616. doi: 10.1016/j.heliyon.2024.e39616. eCollection 2024 Nov 15.
3
Amnion-derived hydrogels as a versatile platform for regenerative therapy: from lab to market.
Front Bioeng Biotechnol. 2024 Feb 26;12:1358977. doi: 10.3389/fbioe.2024.1358977. eCollection 2024.
5
Applications of the amniotic membrane in tissue engineering and regeneration: the hundred-year challenge.
Stem Cell Res Ther. 2022 Jan 10;13(1):8. doi: 10.1186/s13287-021-02684-0.
6
Bone-Marrow Stem Cells and Acellular Human Amniotic Membrane in a Rat Model of Heart Failure.
Life (Basel). 2021 Sep 13;11(9):958. doi: 10.3390/life11090958.

本文引用的文献

1
Cell-Based Therapies for Myocardial Regeneration in Heart Failure: 20 Years of Debate.
Braz J Cardiovasc Surg. 2020 Aug 1;35(4):VIII-XI. doi: 10.21470/1678-9741-2020-0362.
2
Development of Injectable Amniotic Membrane Matrix for Postmyocardial Infarction Tissue Repair.
Adv Healthc Mater. 2020 Jan;9(2):e1900544. doi: 10.1002/adhm.201900544. Epub 2019 Nov 28.
4
Evaluating the efficacy of tissue-engineered human amniotic membrane in the treatment of myocardial infarction.
Regen Med. 2019 Feb;14(2):113-126. doi: 10.2217/rme-2018-0024. Epub 2019 Feb 11.
5
Angiogenic potential of extracellular matrix of human amniotic membrane.
Tissue Eng Regen Med. 2016 Jun 9;13(3):211-217. doi: 10.1007/s13770-016-9057-6. eCollection 2016 Jun.
6
Anti-Inflammatory and Anti-Fibrotic Effects of Human Amniotic Membrane Mesenchymal Stem Cells and Their Potential in Corneal Repair.
Stem Cells Transl Med. 2018 Dec;7(12):906-917. doi: 10.1002/sctm.18-0042. Epub 2018 Sep 10.
7
Stem cell characteristics and the therapeutic potential of amniotic epithelial cells.
Am J Reprod Immunol. 2018 Oct;80(4):e13003. doi: 10.1111/aji.13003. Epub 2018 Jun 29.
9
Mesenchymal stem cells seeded on a human amniotic membrane improve liver regeneration and mouse survival after extended hepatectomy.
J Tissue Eng Regen Med. 2018 Apr;12(4):1062-1073. doi: 10.1002/term.2607. Epub 2017 Dec 5.
10
Epidemiology of Left Ventricular Systolic Dysfunction and Heart Failure in the Framingham Study: An Echocardiographic Study Over 3 Decades.
JACC Cardiovasc Imaging. 2018 Jan;11(1):1-11. doi: 10.1016/j.jcmg.2017.08.007. Epub 2017 Oct 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验